BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37932712)

  • 1. Epidemiologic changes of infectious diseases in the post-SARS era in China, 2004-2018.
    Luo Y; Wu B; Xu Y; Ai L; Lv H; Wu J; Tan W
    BMC Public Health; 2023 Nov; 23(1):2171. PubMed ID: 37932712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
    Dong Y; Wang L; Burgner DP; Miller JE; Song Y; Ren X; Li Z; Xing Y; Ma J; Sawyer SM; Patton GC
    BMJ; 2020 Apr; 369():m1043. PubMed ID: 32241761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and disparities in 44 national notifiable infectious diseases in China: An analysis of national surveillance data from 2010 to 2019.
    Du M; Wang R; Yuan J; Lv X; Yan W; Liu Q; Qin C; Xiang N; Zhu L; Liang W; Liu M; Liu J
    J Med Virol; 2023 Jan; 95(1):e28353. PubMed ID: 36443103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study.
    Yang S; Wu J; Ding C; Cui Y; Zhou Y; Li Y; Deng M; Wang C; Xu K; Ren J; Ruan B; Li L
    Lancet Infect Dis; 2017 Jul; 17(7):716-725. PubMed ID: 28412150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological features and trends in the mortality rates of 10 notifiable respiratory infectious diseases in China from 2004 to 2020: Based on national surveillance.
    Zhao N; Wang S; Wang L; Shi Y; Jiang Y; Tseng TJ; Liu S; Chan TC; Zhang Z
    Front Public Health; 2023; 11():1102747. PubMed ID: 36875408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 epidemic and other notifiable infectious diseases in China.
    Bai BK; Jiang QY; Hou J
    Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics and trends of notifiable infectious diseases in China from 1986 to 2016.
    Jiang Y; Dou X; Yan C; Wan L; Liu H; Li M; Wang R; Li G; Zhao L; Liu Z; Zhao X; Wan K
    J Glob Health; 2020 Dec; 10(2):020803. PubMed ID: 33214900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal and Seasonal Trends of Class A and B Notifiable Infectious Diseases in China: Retrospective Analysis.
    Zheng J; Zhang N; Shen G; Liang F; Zhao Y; He X; Wang Y; He R; Chen W; Xue H; Shen Y; Fu Y; Zhang WH; Zhang L; Bhatt S; Mao Y; Zhu B
    JMIR Public Health Surveill; 2023 Apr; 9():e42820. PubMed ID: 37103994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and trends of 17 notifiable bacterial infectious diseases in China, 2004-2019.
    Zhu Y; Lin S; Dong S; Zhang C; Shi L; Ren X; Li Z; Wang L; Fang L
    BMC Infect Dis; 2023 May; 23(1):273. PubMed ID: 37131164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.
    Zhou Q; Hu J; Hu W; Li H; Lin GZ
    BMC Infect Dis; 2023 Jun; 23(1):375. PubMed ID: 37316780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.
    Hu J; Li W; Peng Z; Chen Z; Shi Y; Zheng Y; Liang Q; Wu Y; Liu W; Shen W; Dai Q; Zhu L; Bao C; Zhu F; Chen F
    J Glob Health; 2023 Sep; 13():04107. PubMed ID: 37681663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological characteristics of infectious diseases of group A, B and C among Chinese students' population].
    Dong YH; Chen MM; Wang LP; Xing Y; Song Y; Zou ZY; Dong B; Li ZJ; Ma J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):498-505. PubMed ID: 34145851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004-2021: a population-based surveillance study.
    Zhao N; Guo X; Wang L; Zhou H; Gong L; Miao Z; Chen Y; Qin S; Yu Z; Liu S; Wang S
    Front Public Health; 2023; 11():1177965. PubMed ID: 37213628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious diseases among elderly persons: Results from a population-based observational study in Shandong province, China, 2013-2017.
    Du WY; Yin CN; Wang HT; Li ZW; Wang WJ; Xue FZ; Zhao L; Cao WC;
    J Glob Health; 2021; 11():08010. PubMed ID: 35003717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.